Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00235495 · ClinicalTrials.gov registry record · Phase 3

Albumin in Acute Ischemic Stroke Trial

A Phase 3 study, sponsored by University of Miami.

Terminated
Registry status
Phase 3
Development phase
841
Enrollment target

NCT00235495: Clinical Trial Phase 3 study, sponsored by University of Miami.

NCT00235495 is a Phase 3 study that was terminated before completion, run by University of Miami. The registered enrollment target is 841 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00235495, a Phase 3 study, was terminated before completion, sponsored by University of Miami.

TERMINATED
Registry status
Phase 3
Development phase
841 participants
Enrollment target

Study Summary

The goal of the trial is to determine whether human albumin, administered within 5 hours of symptom onset, improves the 3-month outcome of subjects with acute ischemic stroke.

Primary Outcome

The National Institutes of Health Stroke Scale (NIHSS) is a systematic assessment tool that provides a quantitative measure of stroke-related neurologic deficit. The scores range from 0 to 42 with a score of greater than 20 indicating severe neurologic deficit. The mRS ranges from 0-6 representing perfect health without symptoms to death. A score of 0 is no symptoms at all and a score of 1 is no significant disability. Able to carry out all usual duties and activities.

Interventions

  • DRUG Saline
  • BIOLOGICAL Albumin

Trial Details

FieldValue
Enrollment Target 841 participants
Start Date 2006-06
Est. Completion 2013-02
Phase Phase 3
University of Miami

721 total trials

Why NCT00235495 stopped before completion

NCT00235495 is an interventional study that assigns participants to a tested intervention. The registered 841 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.

The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.

NCT00235495 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00235495 about?

NCT00235495 is a clinical study titled "Albumin in Acute Ischemic Stroke Trial". The goal of the trial is to determine whether human albumin, administered within 5 hours of symptom onset, improves the 3-month outcome of subjects with acute ischemic stroke.

What is the current status of trial NCT00235495?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 841 participants. The study started on 2006-06. Estimated completion is 2013-02.

What interventions are being tested in trial NCT00235495?

The interventions under investigation include: Saline (DRUG), Albumin (BIOLOGICAL).

Who is sponsoring clinical trial NCT00235495?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00235495's enrollment target sits among peer trials

841 392nd of 2000 higher than 1,609 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06027788 · 842 participants · NA

    CTSN Embolic Protection Trial

  • NCT04831580 · 840 participants · NA

    A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

  • NCT04976881 · 840 participants · NA

    Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes

  • NCT04985903 · 840 participants · NA

    Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00235495, the US trial registry maintained by the National Library of Medicine. NCT00235495 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.